|
GB201600053D0
|
|
Flavonoids medicine intermediate 1,1-diphenyl-1-propene synthesis method
|
|
GB201600056D0
|
|
Clotrimazole medicine intermediate o-chlorobenzonitrile synthesis method
|
|
GB201600051D0
|
|
Nonsteroidal anti-inflammatory drug diclofenac medicine intermediate cyclohexene synthesis method
|
|
GB201600052D0
|
|
Perhexiline medicine intermediate a- (2,2-diphenyl-vinyl) pyridine synthesis method
|
|
GB201600061D0
|
|
Methotrexate sodium medicine intermediatediethanol shrink acrolein synthesis method
|
|
GB201600058D0
|
|
Methotrexate medicine intermediate malononitrate synthesis method
|
|
GB201600050D0
|
|
lmidaclothiz pharmaceutical intermediate 2-chloro-5-methylthiazole synthesis method
|
|
GB201600066D0
|
|
Phentolamine mesylate medicine intermediate chloroacetonitrile synthesis method
|
|
GB201600047D0
|
|
Norepinephrine oxazoline cephalosporin intermediates 2-(1H-1-tetrazolyl)Acetic acid synthesis method
|
|
GB201600070D0
|
|
Carbenicillin sodium medicine intermediate benzylidene malonate synthesis method
|
|
GB201600068D0
|
|
Haloperidol medicine intermediate 4-chloro-nitrile synthesis method
|
|
GB201600045D0
|
|
Deazapurine medicine intermediate azide benzene synthesis method
|
|
GB201600059D0
|
|
Hexyl resorcinol medicine intermediate 2-hepatone synthesis method
|
|
GB201600062D0
|
|
Pyridazinones medicine intermediate succinicanhydride synthesis method
|
|
GB201600057D0
|
|
Diazepam medicine intermediate ketorolac acid anhydride synthesis method
|
|
GB201600074D0
|
|
Clofibrate medicine intermediate chlorophenoxy-acetic isobutyrate synthesis method
|
|
GB201600064D0
|
|
Pancuronium pharmaceutical intermediate 2-bromopropene synthesis method
|
|
GB201600060D0
|
|
ltaconic acid intermediate3-carboxy-2-pentene-1,5-acid synthesis method
|
|
GB201600073D0
|
|
Nafcillin sodium medicine intermediate ethoxy-1-naphthaldehyde synthesis method
|
|
GB201600065D0
|
|
Ketamine medicine intermediate cyclopenteno synthesis method
|
